DRESS Associated With Agranulocytosis in a Patient Treated WIth Oxacillin By Diana Ernst, RPh Publish Date March 22, 2019
Risk of New-Onset Psychosis Examined Among ADHD Patients Treated With Stimulants By Diana Ernst, RPh Publish Date March 22, 2019
Investigational Treatment for Farber Disease Gets Fast Track, Rare Pediatric Disease Designations By Da Hee Han, PharmD Publish Date March 22, 2019
First-in-Class Device Approved to Treat Moderate to Severe Chronic Heart Failure By Steve Duffy Digital Content Editor Publish Date March 22, 2019
Data Submitted to FDA Clarify Interaction Between Addyi and Alcohol By Diana Ernst, RPh Publish Date March 21, 2019
Alzheimer Disease Trials Discontinued Following Disappointing Results With Aducanumab By Diana Ernst, RPh Publish Date March 21, 2019
Does Ranolazine Potentiate the Effects of ACE Inhibitors, Angiotensin Receptor Blockers? By Cassandra Pardini, PharmD Publish Date March 21, 2019
Sunosi Approved for Excessive Daytime Sleepiness With Narcolepsy, OSA By Da Hee Han, PharmD Publish Date March 21, 2019
Zulresso Approved as First Treatment for Postpartum Depression By Da Hee Han, PharmD Publish Date March 20, 2019
FDA Places Clinical Hold on Venetoclax Trials for Multiple Myeloma By Da Hee Han, PharmD Publish Date March 20, 2019
FDA Warns Company Selling Misbranded Drugs With False Claims By Steve Duffy Digital Content Editor Publish Date March 20, 2019
High Discordance Between LDL-C, Lp(a) Reduction in Response to Evolucumab By Brandon May Publish Date March 20, 2019
